Kimberly-Clark – Top Discussion Among Investors Today

By Tamara Parker • Tuesday, December 05 19:04 • Permanent Link

Large-cap Consumer Discretionary company Kimberly-Clark has moved -2.2% so far today on a volume of 1,996,916, compared to its average of 1,756,736. In contrast, the S&P 500 index moved -0.0%.

Kimberly-Clark trades -7.21% away from its average analyst target price of $130.88 per share. The 17 analysts following the stock have set target prices ranging from $111.0 to $153.0, and on average have given Kimberly-Clark a rating of hold.

If you are considering an investment in KMB, you'll want to know the following:

Kimberly-Clark's current price is 692.2% above its Graham number of $15.33, which implies that at its current valuation it does not offer a margin of safety
Kimberly-Clark has moved -9.0% over the last year, and the S&P 500 logged a change of 17.0%
Based on its trailing earnings per share of 5.2, Kimberly-Clark has a trailing 12 month Price to Earnings (P/E) ratio of 23.4 while the S&P 500 average is 15.97
KMB has a forward P/E ratio of 17.1 based on its forward 12 month price to earnings (EPS) of $7.1 per share
The company has a price to earnings growth (PEG) ratio of 1.91 — a number near or below 1 signifying that Kimberly-Clark is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 60.36 compared to its sector average of 4.24
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide.
Based in Dallas, the company has 44,000 full time employees and a market cap of $41.04 Billion. Kimberly-Clark currently returns an annual dividend yield of 3.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.